Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency
- PMID: 12815589
- DOI: 10.1002/humu.10226
Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency
Abstract
Mutations in electron transfer flavoprotein (ETF) and its dehydrogenase (ETFDH) are the molecular basis of multiple acyl-CoA dehydrogenation deficiency (MADD), an autosomal recessively inherited and clinically heterogeneous disease that has been divided into three clinical forms: a neonatal-onset form with congenital anomalies (type I), a neonatal-onset form without congenital anomalies (type II), and a late-onset form (type III). To examine whether these different clinical forms could be explained by different ETF/ETFDH mutations that result in different levels of residual ETF/ETFDH enzyme activity, we have investigated the molecular genetic basis for disease development in nine patients representing the phenotypic spectrum of MADD. We report the genomic structures of the ETFA, ETFB, and ETFDH genes and the identification and characterization of seven novel and three previously reported disease-causing mutations. Our molecular genetic investigations of these nine patients are consistent with three clinical forms of MADD showing a clear relationship between the nature of the mutations and the severity of disease. Interestingly, our data suggest that homozygosity for two null mutations causes fetal development of congenital anomalies resulting in a type I disease phenotype. Even minute amounts of residual ETF/ETFDH activity seem to be sufficient to prevent embryonic development of congenital anomalies giving rise to type II disease. Overexpression studies of an ETFB-D128N missense mutation identified in a patient with type III disease showed that the residual activity of the mutant enzyme could be rescued up to 59% of that of wild-type activity when ETFB-D128N-transformed E. coli cells were grown at low temperature. This indicates that the effect of the ETF/ETFDH genotype in patients with milder forms of MADD, in whom residual enzyme activity allows modulation of the enzymatic phenotype, may be influenced by environmental factors like cellular temperature.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.Clin Chim Acta. 2009 Jun 27;404(2):95-9. doi: 10.1016/j.cca.2009.02.015. Epub 2009 Mar 3. Clin Chim Acta. 2009. PMID: 19265687
-
Assignment of Etfdh, Etfb, and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human.Genomics. 1996 Apr 1;33(1):131-4. doi: 10.1006/geno.1996.0170. Genomics. 1996. PMID: 8617498
-
Electron transfer flavoprotein deficiency: functional and molecular aspects.Mol Genet Metab. 2006 Jun;88(2):153-8. doi: 10.1016/j.ymgme.2006.01.009. Epub 2006 Feb 28. Mol Genet Metab. 2006. PMID: 16510302
-
[Glutaric aciduria type 2].Nihon Rinsho. 2002 Apr;60 Suppl 4:743-6. Nihon Rinsho. 2002. PMID: 12013989 Review. Japanese. No abstract available.
-
Glutaric aciduria type II: review of the phenotype and report of an unusual glomerulopathy.Am J Med Genet. 1989 Mar;32(3):395-401. doi: 10.1002/ajmg.1320320326. Am J Med Genet. 1989. PMID: 2658591 Review.
Cited by
-
Persistent hypoglycemia associated with lipid storage myopathy in a paint foal.J Vet Intern Med. 2018 Jul;32(4):1442-1446. doi: 10.1111/jvim.15218. Epub 2018 Jun 29. J Vet Intern Med. 2018. PMID: 29957835 Free PMC article.
-
Role of RNA in Molecular Diagnosis of MADD Patients.Biomedicines. 2021 May 4;9(5):507. doi: 10.3390/biomedicines9050507. Biomedicines. 2021. PMID: 34064479 Free PMC article.
-
Human inborn errors of long-chain fatty acid oxidation show impaired inflammatory responses to TLR4-ligand LPS.FASEB Bioadv. 2024 Aug 19;6(9):337-350. doi: 10.1096/fba.2024-00060. eCollection 2024 Sep. FASEB Bioadv. 2024. PMID: 39399475 Free PMC article.
-
A novel ETFB mutation in a patient with glutaric aciduria type II.Hum Genome Var. 2015 Jun 18;1:15016. doi: 10.1038/hgv.2015.16. eCollection 2015. Hum Genome Var. 2015. PMID: 27081516 Free PMC article.
-
Disease mechanisms and protein structures in fatty acid oxidation defects.J Inherit Metab Dis. 2010 Oct;33(5):547-53. doi: 10.1007/s10545-010-9046-1. Epub 2010 Feb 12. J Inherit Metab Dis. 2010. PMID: 20151199
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous